ANN ARBOR - Fifth Eye Inc., a digital health predictive analytics company, has received a $2.36 million investment from Invest Michigan, Biosciences Research and Commercialization Center, and 33 private angel investors. Fifth Eye develops real-time predictive analytic patient data software to give doctors and nurses a heads up hours in advance about impending trouble ranging
ANN ARBOR - Genomic Data Search company Genomenon has been awarded a Phase 2 Small Business Innovation Research grant by the National Institutes of Health. The amount was not disclosed. The grant will be used to develop and apply machine learning and artificial intelligence algorithms to variant interpretation, the single biggest hurdle in scaling the
PORTAGE — Pfizer Inc. is the first manufacturer to take advantage of the Good Jobs for Michigan incentive program signed into law a year ago by Gov. Rick Snyder. The pharmaceutical giant said today it will invest $465 million into a two-story, 400,000-square-foot building at its Portage campus, which will serve as a sterile drug manufacturing facility.
GRAND RAPIDS – Carol Health, a mobile app-based, on-demand home health service, has joined Great Lakes Health Connect to provide nurses with access to Virtual Integrated Patient Record, a cloud-based system that stores and organizes the health information of over nine million patients. More than 200 organizations across the state contribute health information into the
KALAMAZOO - Vestaron Corp. seeks to raise $12 million in investments to enable the company to bring to market its environmentally friendly pesticide based on spider venom. Vestaron closed in late June on the first round of the capital raise, netting more than $4.2 million from five existing investors. The capital will go toward producing
LIVONIA - Digital Insulin enhancement company, Hygieia, has cut a three-year deal with Blue Cross Blue Shield of Michigan to make its Nav Insulin Guidance Service available at no cost and with no co-pays to BCBSM members with Type 2 diabetes, starting with at-risk populations in Southeast Michigan. Financial terms were not disclosed. The agreement
ANN ARBOR - Genomenon has struck a co-marketing agreement with Fluidigm Corp. to offer evidence-based genomic panel design services for translational and clinical disease research. Through the Fluidigm-Genomenon joint panel design services offering, researchers will be able to accelerate the design of disease-specific next-generation sequencing, genotyping, and real-time PCR panels for use with highly efficient
GRAND RAPIDS — Spectrum Health has committed $7.5 million to a new Chicago-based venture capital fund that backs emerging heath care technologies. The commitment to invest $2.5 million annually over three years into 7wire Ventures’ Connected Consumer Health Fund comes from Spectrum Health Ventures LLC, the $100 million venture capital fund the health system formed in early 2017. By investing
ANN ARBOR — Pharma startup Esperion Therapeutics announced this week the appointment of Jay P. Shepard as a Class III Director, with a term expiring at the 2019 annual meeting of stockholders. “Jay’s experience supporting the launch and commercialization of biopharmaceutical products will be invaluable as we advance the bempedoic acid product franchise through the
ANN ARBOR — Esperion Therapeutics Inc. announced positive top-line results from the third of five pivotal Phase 3 studies expected to be reported this year to evaluate the efficacy in lowering so-called bad cholesterol. The tests were done on Esperion's, lead drug candidate, bempedoic acid, at a dose of 180 milligrams, vs. placebo in high-risk patients
